期刊： LEUKEMIA RESEARCH, 2022; 113 ()
Protein kinase C alpha (PKC alpha), belonging to ser/thr protein kinase, perform various biological functions. Over expression of PKC alpha has been o......
期刊： LEUKEMIA RESEARCH, 2022; 115 ()
The aim of study was to assess the clinical characteristics, survival outcomes of newly diagnosed multiple myeloma (NDMM) patients with extramedullary......
期刊： LEUKEMIA RESEARCH, 2022; 115 ()
Mantle cell lymphoma (MCL) is a rare B cell malignancy. The classical MCL subtype is positive for translocation t (11;14), SOX11 expression, and chara......
期刊： LEUKEMIA RESEARCH, 2022; 116 ()
Long noncoding RNAs (lncRNAs) are identified as key players in the initiation, development, and prognosis of chronic myeloid leukemia (CML). Some lncR......
期刊： LEUKEMIA RESEARCH, 2022; 118 ()
More than 90% of NPM1-mutated acute myeloid leukaemia (NPM1mut AML) patients have been determined to harbour other known concurrent mutations. However......
期刊： LEUKEMIA RESEARCH, 2022; 121 ()
Cardiotoxicity after allogeneic stem cell transplantation (SCT) is associated with a high rate of mortality and worsening quality of life. The relatio......
期刊： LEUKEMIA RESEARCH, 2022; 123 ()
Measurable residual disease (MRD) assessment provides a potent indicator of the efficacy of anti-leukemic therapy. It is unknown, however, whether int......
期刊： LEUKEMIA RESEARCH, 2022; 122 ()
Background: The objectives of this study were to investigate the mutation profiles of targeted genes and copy number variations (CNVs) in normal cytog......
期刊： LEUKEMIA RESEARCH, 2022; 112 ()
Background: It is increasingly appreciated that some patients with cancer will experience financial burden due to their disease but little is known sp......
期刊： LEUKEMIA RESEARCH, 2022; 114 ()
Genetic differences may be associated with the response to tyrosine kinase inhibitor (TKI) in patients with chronic myeloid leukemia (CML). In this st......
期刊： LEUKEMIA RESEARCH, 2022; 114 ()
Background: Information on the outcomes and treatments of early-stage (I/II) primary cutaneous marginal zone lymphoma (PCMZL) is limited. This study a......
期刊： LEUKEMIA RESEARCH, 2022; 116 ()
Primary effusion lymphoma (PEL) is an aggressive B-cell non-Hodgkin lymphoma in immunocompromised individuals such as AIDS patients. PEL shows a poor ......
期刊： LEUKEMIA RESEARCH, 2022; 112 ()
Acute myeloblastic leukemia (AML) is one of the most common types of blood malignancies that results in an AML-associated high mortality rate each yea......
期刊： LEUKEMIA RESEARCH, 2022; 122 ()
The Phase 3 ICARIA-MM (NCT02990338) and IKEMA (NCT03275285) studies demonstrated that isatuximab (Isa) plus pomalidomide (P) and dexamethasone (d; Isa......
